🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

86 results for “Eye” Clear

  1. Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial

  2. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial

  3. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial

  4. NAABAK eyedrops

    Laboratoire HRA Pharma

    Allergic Conjunctivitis

    approved small molecule completed

    1 trial

  5. Plasma rich in growth factors, -

    The George Institute

    Glaucoma, Dry eye disease

    approved small molecule active

    1 trial

  6. Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución, Hidrathea 9 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial

  7. Rebamipide 2% ophthalmic solution

    Samsung Bioepis NL B.V.

    Dry Eye Disease (DED)

    approved small molecule active

    1 trial

  8. SYSTANE™ Hydration Lubricant Eye Drops

    Hospital Authority, Hong Kong

    Dry Eye Syndromes

    approved small molecule active

    1 trial

  9. Softacort 3,35 mg/ml colirio en solución en envases unidosis

    Laboratorios Tillomed Spain S.L.U

    Dry Eye and Meibomian Gland Dysfunction

    approved small molecule active

    1 trial

  10. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  11. Oral microbiota

    Hospital Authority, Hong Kong

    Dry Eye Syndrome

    other active

    1 trial

  12. Umbilical cord serum eyedrops

    Hospital Authority, Hong Kong

    Recurrent Corneal Erosion

    small molecule completed

    1 trial

  13. Usual care

    Eye & ENT Hospital of Fudan University

    Vestibular Disorder

    small molecule active

    1 trial

  14. trans-resveratrol

    Hong Kong Baptist University

    Eye Disease

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources